<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0005">
 <label>5</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Cascioferro</surname>
    <given-names>S</given-names>
   </string-name>, 
   <string-name>
    <surname>Parrino</surname>
    <given-names>B</given-names>
   </string-name>, 
   <string-name>
    <surname>Spanò</surname>
    <given-names>V</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2017</year>;
  <volume>142</volume>:
  <fpage>328</fpage>–
  <lpage>75</lpage>.
  <pub-id pub-id-type="pmid">28851503</pub-id>
 </mixed-citation>
</ref>
